Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q2 2023 Earnings Call Transcript

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q2 2023 Earnings Call Transcript August 8, 2023

Amicus Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $0.12.

Operator: Good morning, ladies and gentlemen and welcome to the Amicus Therapeutics Second Quarter 2023 Financial Results Conference Call and webcast. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mr. Andrew...